TNFRSF8 and neoplasm: In contrast, a complete loss of 5-hmC expression was observed in 63% of LyP and 53% of pcALCL cases; such a lack of expression was a hallmark of CD30+ LPD, and this may help to distinguish neoplastic diseases from CD30+ inflammatory infiltrates [40].